Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Argus Upgrades Pfizer (PFE) to Buy
-
Argus Downgrades Pfizer (PFE) to Hold
-
Notable Analyst Rating Changes 11/25: (PFE) (IMGN) (PANW) Upgraded; (SUNE) (PTCT) (TIF) Downgraded
-
Notable Analyst Rating Changes 07/28: (CPN) (XRX) (QRE) Upgraded; (MNST) (DSW) (PFE) Downgraded
-
Notable Analyst Rating Changes 07/02: (JPM) (ZQK) (STX) Upgraded; (ABX) (PFE) (CACI) Downgraded
-
Streetinsider.com Pre-Open Movers 06/28: (DNDN) (MCP) (PSUN) Higher; (BBRY) (AMED) (GTIV) Lower (more...)
-
Unusual 11 Mid-Day Movers 12/21: (HALO) (ASCA) (FCFC) Higher; (HEB) (EDMC) (RIMM) Lower
-
Notable Analyst Rating Changes 05/21: CCL, MA, CAP, KEY Upgraded; BRCD, WEN, OEH, DRI Downgraded
-
David Moenning's Daily State of the Markets: 4/28
-
David Moenning's Daily State of the Markets: 2/9

